Difamilast Ointment, a Topical PDE4 Inhibitor, for Pediatric Cheilitis Granulomatosa: A Steroid‐Sparing Outcome

Key Points

• Difamilast ointment shows a significant impact on pediatric cheilitis granulomatosa, promoting healing without steroids.
• Key evidence indicates improved symptoms observed within weeks of treatment, enhancing comfort for young patients.
• This observational analysis highlights the role of difamilast as a topical PDE4 inhibitor, potentially reducing treatment side effects.
• These findings suggest further exploration of difamilast in pediatric dermatology to confirm long-term benefits and safety.